Therapeutic management of vitiligo;Consideraciones terapeuticas en el manejo del vitiligo

Medicina Cutanea Ibero-Latino-Americana

Volumn 27, Issue 5, 1999, Pages 173-188

  Falabella, Rafael F ^a,b   Escobar, Carlos E R ^a   Barona, María I C ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b CENTRO MÉDICO IMBANACO   (Colombia)

Author keywords

Medical; Surgical; Therapy; Vitiligo

Indexed keywords

FLUOROURACIL; KHELLIN; LEVAMISOLE; PHENYLALANINE;

CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; PATHOGENESIS; PHOTOTHERAPY; PUVA; REVIEW; TREATMENT INDICATION; VITILIGO;

EID: 0033492011     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. NORDLUND, J.J., MAJUNDER, P.P.: Recent investigations on vitiligo vulgaris, Dermatol Clin, 1997; 15: 69-78.
2. HANN, S.K., LEE, H.J.: Segmental vitiligo: Clinical findings in 208 patients. J Am Acad Dermatol, 1996; 35: 671-4.
3. ORTONNE, J.P., BOSE, S.K.: Vitiligo: Where do we stand? Pigment Cell Res, 1993; 6: 61-72.
4. LE POOLE, I.C., DAS, P.K., VAN DEN WIJNGAARD R.M., BOS J.D., WESTERHOF W.: Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol, 1993; 2: 145-53.
5. SCHALLREUTER, K.U., WOOD, J.M., LEMKE, K.R. et al: Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case stydy on 33 patients Dermatology, 1995; 190: 223-9.
6. BYSTRYN, J.C.: Immune mechanisms in vitiligo. Immunor Ser, 1989; 46: 447-73.
7. GRIMES, P.E., SEVALL, J.S., VOJDANI, A.: Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol, 1996; 35: 21-6.
8. HAUTMANN, G., PANCONESI, E.: Vitiligo: A psycholagically influenced and influencing disease. Clin Dermatol, 1997; 15: 879-90.
9. ORTONNE, J.P., SCHMITT, D., THIVOLET, J.: UVA-induced repigmentation of vitiligo: scanning electron microcopy of hair follicles. J Invest Dermatol, 1980; 74: 40-2.
10. NORRIS, D.A., HORIKAWA, T., MORELLI, J.G.: Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res, 1994; 7: 193-203.
11. GRICHNIK, J.M., ALI, W.N., BURCH, J.A., et al: KIT expression reveals a population of precursor melanocytes in human skin. J Invest Dermatol, 1996; 106: 967-71.
12. DUTTA, A.K., MANDAL, S.B.: A clinical study of 650 vitiligo cases and their classification. Indian J Dermatol, 1969; 14: 103-11.
13. LE POOLE, I.C., VAN DEN WIJNGAARD, R.M., WESTERHOF, V., et al: Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J. Invest Dermatol, 1993; 100: 816-22.
14. IYENGAR, B., MISRA, R.S.: Neural differentiation of melanocytes in vitiliginous skin. Acta anat Basel, 1988; 133: 62-5.
15. LE POOLE, I.C., DAS, P.K. Micrioscopic changes in vitiligo. Clin Dermatol, 1997; 15: 863-73.
16. MORELLI, J.G., KINCANNON, J., YOHN, J.J.: et al: Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol, 1992; 98: 290-5.
17. HORIKAWA, T., NORRIS, D.A., YOHN, J.J.: et al: Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol, 1995; 104: 256-9.
18. LE POOLE, I.C., VAN DEN WIJNGAARD, K.M., WESTERHOF, W.; et al. Organotypic culture of human skin to study melanocyte migration. Pigment Cell Res, 1994; 7: 33-43.
19. LE POOLE, I.C., VAN DEN WIJNGAARD, R.M., WESTERHOF, W.: et al. tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion. Br J Dermatol, 1997; 137: 171-8.
20. HANN, S.K., PARK, Y.K., CHUN, W.H.: Clinical features of vitiligo. Clin Dermatol, 1987; 15: 891-7.
21. CHUN, W.H., HANN, S.K: The progression of nonsegmental vitiligo: clinical analysis of 318 patients. Int J Dermatol, 1997; 36: 908-10.
22. NJOO, M.D., DAS, P.K., BOS, J.D., WESTERHOF; W.: Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol, 1999; 135: 407-13.
23. HALDER, R.M.: Childhook Vitiligo. Clin Dermatol, 1997; 15: 899-906.
24. GRIMES, P.E.: Psoralen photochemotherapy for vitiligo. Clin Dermatol, 1997; 15: 921-6.
25. EL MOFTY, A.M., EL SAWALHY, H., EL MOFTY, M.: Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy. Int J Dermatol, 1994; 33: 588-92.
26. WILDFANG, I.L., JACOBSEN, F.K., THESTRUP PEDERSEN, K.: PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Derm Venereol, 1992; 72: 305-6.
27. HALDER, R.M., Topical PUVA therapy for vitiligo. Dermatol Nurs, 1991; 3: 178-80, 98.
28. Question of the month. What is the role of PUVA therapy in the treatment of vitiligo? Ann Dermatol Venereol, 1994; 121:273-8.
29. HANN, S.K., CHO, M.Y., IM, S., PARK, Y.K.: Treatment of vitiligo with oral 5-methoxypsoralen. J Dermatol, 1991; 18: 324-9.
30. GRIMES, P.E., MINUS, H.R., CHAKRABARTY, S.G.: Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol, 1982; 7: 771-8.
31. AL ABOOSI, M.M., AJAM, Z.A.: Oral photochemotherapy in vitiligo: follow-up, patient compliance. Int J Dermatol, 1995; 34: 206-8.
32. CUI, J., SHEN, L.Y., WANG, G.C.: Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol, 1991; 97: 410-6.
33. HANN, S.K., LEE, H.J.: Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol, 1996; 35: 671-4.
34. FINCO, O., CUCCIA, M., MARTINETTI, M.: et al. Age of onset in vitiligo: relationship HLA supratypes. Clin Genet, 1991; 39: 48-54.
35. PARSAD, D., SAINI, R., VERMA, N.: Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology, 1998; 197: 167-70.
36. WESTERHOF, W, NIEUWEBOER KROBOTOVA, L.: Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-B. Arch Dermatol, 1997; 133: 1525-8. 1528.
37. MANDEL, A.S., HABERMAN, H.F., PAWLOWSKI, D.: et al. Non PUVA non-surgical therapies for vitiligo. Clin Dermatol, 1997; 15: 907-19.
38. KOSTER, W., WISKEMANN, A.: Phototherapie mit UV-B bei Vitiligo. Z Hautkr, 1990; 65: 1022-4-9.
39. JUHLIN, L., OLSSON, M.J.: Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol, 1997; 77: 460-2.
40. GOLDSTEIN, E., HABERMAN, H.F., MENON, I.A.: et al. Non-psoralen treatment of vitiligo. Part I. Cosmetics, systemic coloring agents, and corticosteroids. Int J Dermatol, 1992; 31: 229-36.
41. BLEEHEN, S.S.: The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies. Br J Dermatol, 1976; 94: 43-50.
42. CLAYTON, R.: Adouble-blind trial of 0-05% clobetasol propnonate in the treatment of vitiligo. Br J Dermatol, 1977; 96: 71-3.
43. KUMARI, J.: Vitiligo treated with topical clobetasol propionate. Arch Dermatol, 1984; 120: 631-5.
44. GERALDEZ, C.B., GUTIERREZ, G.T.: A clinical trial of clobetasol propionate in Filipino vitiligo patients. Clin Ther, 1987; 9: 474.82.
45. LIU, X.Q., SHAO, C.G., JIN, P.Y.: et al. Treatment of localized vitiligo with ulobetasol cream. Int J Dermatol, 1990; 29: 295-7.
46. KHALID, M., MUJATABA, G.: Response of segmental vitiligo to 0.05% clobetasol propionate cream. Int J Dermatol, 1998; 37: 705-8.
47. VASISTHA, L.K., SINGH, G.: Vitiligo and intralesional steroids. Indian J Med Res, 1990; 69: 308-11.
48. KANDIL, E.: Treatment of localized vitiligo with intradermal infections of triamcinolone acetonide. Dermatologica, 1970; 140: 195-206.
49. PASRICHA, J.S., KHAITAN, B.K.: Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol, 1993; 32: 753-7.
50. KANWAR, A.J., DHAR, S., DAWN, G.: Oral minipulse therapy in vitiligo [letter]. Dermatology. 1995; 190: 251-2.
51. ABDEL FATTAH, A., ABOUL ENEIN, M.N., WASSEL, G.M.: et al. an approach to the treatment of vitiligo by khellin. Dermatologica, 1982; 165: 136-40.
52. ORTEL, B., TANEW, A., HONIGSMANN, H.: Treatment of vitiligo with khellm and ultraviolet A [see comments] J Am Acad Dermatol, 1988; 18: 693-701.
53. RICCIO, M.L., CORATZA, G., BOVALINI, L.: et al. Investigation of the mutagenic activity in Salmonella typhimurium of the furochrornone khellin, proposed as a therapeutic agent for skin diseases. Mutat Res, 1992; 279: 103-8.
54. JANSEN, T., MEGAHED, M., HOLZLE, E.: et al. Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo. Acta Derm Venereol, 1995; 75: 232-3.
55. DUSCHET P, SCHWARZ, T., PUSCH, M.: et al. Marked increase of liver transaminases after khellin and UVA therapy [letter; comment]. J Am Acad Derrnatol, 1989; 21: 592-4.
56. BECH THOMSEN, N., WULF, H.C.: Treatment with topical khellin in combination with ultraviolet A or solarsimulated radiation is carcinogenic to lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed, 1996; 11: 204-8.
57. SCHULPIS C.H., ANTONIOU, C., MICHAS, T et al. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol. 1989; 6: 332-5.
58. THIELE, B., STEIGLEDER, G.K.: Repigmentierungsbehandlung der Vitiligo mit L-Phenylalanin und UVA-Bestraalung (PAUVA). Z Hautkr, 1987; 62: 519-23.
59. GREINER, D., OCHSENDORF, F.R., MILBRADT, R.: Vitiligo-Therapie mit Phenylalanin/UVA. Katamnestische Untersuchungen nach funf Jahren. Hautarzt, 1994; 45: 460-3.
60. SIDDIQUI A.H., STOLK, L.M., BHAGGOE, R. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology, 1994; 188: 215-8.
61. ROSENBACH, T., WELLENREUTHER, U., NURNBERGER, F.: Vitiligobehandlung mit Phenylalanin und UV-A Hautarzt, 1993; 44: 208-9.
62. SCHALLREUTER, K.U., WOOD, J.M., ZIEGLER, I.: et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta, 1994; 1226: 181-92.
63. SCHALLREUTER, K.U., WOOD, J.M. LEMKE, K.R.: et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology, 1995; 190: 223-9.
64. NORDLUND, J.J., HALDER, R.: Melagenina. an analysis of published and other available data. Dermatologica, 1990; 181: 1-4.
65. PASRICHA, J.S., KHERA, V.: Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol, 1994; 33: 584-7.
66. LANIGAN, S.W.: Failure of Q-switched Nd/YAG laser to repigment vitiligo [letter]. Clin Exp Dermatol, 1996; 21: 245-6.
67. RENFRO, L., GERONEMUS, R.G.: Lack of efficacy of the Q-seitched ruby laser in the treatment of vitiligo [letter] Arch Dermatol, 1992; 128: 277-7.
68. MANDEL, A.S.H.: Opyt primeneniia lazernoi fotokhimioterapii v dermatologii. [Experience with the use of lase photochemotherapy in dermatology] Vestn Dermatol Venerol, 1985; 44-7.
69. MANDEL, A.S.H.: Iavleniia repigmentatsii kozhi v rezul'late lazeroterapii. [Skin repigmentation after laser therapy] Vestn Dermatol Venerol, 1984; 9: 26-9.
70. THISSEN, M., WESTERHOF; W: Laser treatment for further depigmentation in vitiligo. Int J Dermatol, 1997; 36: 386-8.
71. TSUJI, T., HAMADA, T: Tpopically administered fluorouracil in vitiligo. Arch Dermatol, 1983; 119: 722-7.
72. MONK, B.: Topical fluorouracil in vitiligo [letter] Arch-Dermatol. 1985 Jan; 121(1): 25-6.
73. SZEKERES, E., MORVAY; M.: Repigmentation of vitiligo macules treated topically with Wfudix cream. Dermatologica, 1985; 171: 55-9.
74. HALDER, R.M., PHAM, H.N., BREADON, J.Y.: et al. Micropigmentation for the treatment of vitiligo. J Dermatol Surg Oncol, 1989; 15: 1092-8.
75. TIZANO, J.P.: Ladermographie: complement de la chirurgie esthetique. Ann Chir Plast Esthet, 1990; 35: 489-95.
76. AUBIN, F., MAKKI, S., HUMBERT, P.: et al. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation. Arch Dermatol Res, 1994; 286: 30-4.
77. FALABELLA, R., ARRUNATEGUI, A., BARONA, M.I., ALZATE, A.: The minigrafting test for vitiligo: Detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol, 1995; 32: 228-32.
78. FALABELLA, R.: Surgical therapies for vitiligo. Clin Dermatol, 1997; 15: 927-39.
79. GAUTHIER, Y., SURLEVE-BAZEILLE, J.E.: Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J am Acad Dermatol, 1992; 26: 191-4.
80. GAUTHIER, Y.: Les technigues de greffe melanocytaire. Ann Dermatol Venereol, 1995; 122: 627-31.
81. FALABELLA, R.: Epidermal grafting. An original technigue and its application in achromic and granulating areas. Arch Dematol, 1971; 104: 592-600.
82. SKOUGE, J.W., MORISON, W.L., DIWAN, R.V.: et al. Autografting and PUVA. A combination therapy for vitiligo. J Dermatol Surg Oncol, 1992; 18: 357-60.
83. SKOUGE, J., MORISON, W.L.: Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol, 1995; 131: 1257-8.
84. HANN, S.K., IM, S., BONG, H.W.: et al. Treatment of stable vitiligo with autologous epidermal grafting an PUVA. J Am Acad Dermatol, 1995; 32: 943-8.
85. SUGA, Y, BUTT, K.I., TAKIMOTO, R.: et al. Successful treatment of vitiligo with PUVA-pigmented autologous epidermal grafting. Int J Dermatol, 1996; 35: 518-22.
86. FALABELLA, R.: Repigmentation of stable leukoderma by autologous minigrafting. J Dermatol Surg Oncol 1986; 12: 172-9.
87. FALABELLA, R: Treatment of localized vitiligo by autologous minigrafting. Arch Dermatol, 1988; 124: 1649-55.
88. OLSSON, M.J., JUHLIN, L.: Epeidermal sheet grafts for repigmentation of vitiligo and piebaldism with a review of surgical techniques. Acta Derm Venereol, 1997; 77: 463-6.
89. KAHN, A.M., COHEN, M.J.: Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts. Dermatol Surg, 1998; 24: 365-7.
90. FALABELLA, R., ESCOBAR, C., BORRERO, I.: Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol, 1989; 21: 257-64.
91. FALABELLA, R., ESCOBAR, C., BORRERO, I.: Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bering melanocytes. J Am Acad Dermatol, 1992; 26: 230-6.
92. OLSSON, M.J., JUHLIN, L.: Transplantation of melanocytes in vitiligo. Br J Dermatol, 1995; 132: 587-91.
93. LONTZ, V., OLSSON, M.J., MOELLMANN, G., LERNER, A.B.: Pigment cell transplantation for treatment of vitiligo: a progress report. J am Acad Dermatol, 1994; 30: 591-7.
94. OLSSON, M.J., MOELLMANN, G., LERNER, A.B., JUHLIN, L.: Vitiligo: repigmentation with cultured melanocytes after cryostorage. Acta Derm Venereol, 1994; 74: 226-8.
95. FALABELLA, R.: Vitiligo [letter; comment] Acta Derm Venereol (Stockh), 1994; 74: 147-8.